Some seniors will likely pay less out of pocket for drugs, and that obviously matters to patients. How pharma interprets negotiated prices will hugely impact future drug development.
There are strong price reductions, but it also shows there is plenty of room for the industry to continue to make some profits on these drugs, indicating a balanced approach to pricing.
The impact of negotiated prices is far less than politicians have proclaimed, with the industry managing this fine so far, reflecting a more neutral financial perspective on the changes.
22% is not as bad as anticipated earlier this year, indicating that the financial market's initial fears regarding price reductions may have been exaggerated.
Collection
[
|
...
]